Blood

Unclassified acute myeloid leukemia

ORPHA:167714 ↗

Search all Unclassified acute myeloid leukemia trialsAlert me when a trial opens

studies recruiting now

checking live

studies registered in total

checking live

countries with a recruiting site

checking live

recruiting study posted to date

checking live

Recruiting trials

Fetching live from ClinicalTrials.gov. This condition is not yet in our weekly snapshot; live results only.

Keep watching

Get an email when a new Unclassified acute myeloid leukemia study opens.

One email a day at most. Unsubscribe with one click.

Used only for these alerts. Privacy.

Support

Patient organisations

We do not yet list a dedicated organisation for this condition. The directories below are the best route.

NORD ↗GARD ↗Orphanet ORPHA:167714 ↗

A group of conditions, not a single diagnosis

Orphanet classifies “Unclassified acute myeloid leukemia” as a category that groups several related conditions. Trials are usually registered under the specific condition, so the figures above may undercount. Browse the conditions in this group or see the classification on Orphanet.

Treatments being studied

17 approved treatments and 119 in clinical development, from Open Targets (CC BY 4.0). Not medical advice.

Approved: Doxecitine (Doxecitine component of mt-1621 2'-deoxycytidine)Approved: Thioguanine (Lanvis)Approved: AclarubicinApproved: IdarubicinApproved: Daunorubicin (Daunorubicin component of vyxeos)Approved: UbenimexApproved: Gemtuzumab Ozogamicin (Mylotarg)Approved: Enasidenib Mesylate (Idhifa)Approved: Olutasidenib (Rezlidhia)Approved: GilteritinibApproved: Midostaurin (Rydapt)Approved: Tagraxofusp (Elzonris)Approved: Ivosidenib (Tibsovo)Approved: LestaurtinibApproved: Uracil Mustard (Uracil mustard)Approved: QuizartinibApproved: Apalutamide (Erleada)

Phase 3Guadecitabine

Phase 3Elacridar

Phase 3Peginterferon Lambda-1a

Phase 3Sapacitabine

Phase 3Tipifarnib

Phase 3Valspodar (Amdray)

Phase 3Cpi 613

Phase 3Tasisulam

+ 111 more in development

Related conditions

Information, not medical advice. Trial listings are shown as recorded on ClinicalTrials.gov; whether any study is right for you is a decision for you and your clinicians, and eligibility is decided by each research team. Disease information from Orphanet (CC BY 4.0).